Gilead To Buy Cancer Drugmaker Immunomedics For $21 Billion

Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two companies said in a joint statement on Sunday.

from Top Business News- News18.com